gastric disease
Conditions
Interventions
Gold Standard:Electronic upper gastrointestinal endoscope (Olympus,GIF-290)
Index test:Magnetically controlled capsule endoscope (Shenzhen Silicon Intelligent Control Technology Co., LTD, CE-1)
Sponsors
Zhujiang Hospital of Southern Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1.Age 18-70 years old; 2.Health people or population at risk of gastric cancer, including helicobacter pylori infection,and people with a history of stomach disease (gastric polyps, gastric submucosal masses, gastric precancerous lesions and early gastric cancer); 3.Voluntarily participate in the clinical trial and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Pregnancy; 2. Those who have no surgical conditions or refuse to undergo any abdominal surgery; 3. Patients with electronic devices such as cardiac pacemakers, electronic cochlear implants, drug infusion pumps, nerve stimulators or magnetic metal objects, except magnetic resonance image-compatible products; 4. Patients with acute gastrointestinal diseases: judged or suspected to have gastrointestinal obstruction, stenosis, fistula and diverticulum; obvious gastrointestinal bleeding, acute stage of gastrointestinal perforation; acute enteritis, such as bacillary dysentery and acute ulcerative colitis; 5. Patients in poor condition, such as renal insufficiency and congestive heart failure; 6. Patients with mental disorder or psychological disorder that can not cooperate with the examination; 7. Patients who are allergic to polymer materials, patients with dysphagia or esophageal atrophy, patients failed esophageal atrophy or capsule simulant swallowing; 8.Patients after gastric and intestinal resection, patients with intractable constipation or gastrointestinal motility disorder; 9. Other patients that the investigator considers inappropriate to participate in this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Accuracy;Sensitivity;Specificity; | — |
Secondary
| Measure | Time frame |
|---|---|
| Prevalence of different types of gastric focal lesions by magnetically controlled capsule endoscopy;Performance of magnetically controlled capsule endoscopy in detecting gastric focal lesions;Follow-up of population at risk of gastric cancer;Safety evaluation;Application evaluation; | — |
Countries
China
Contacts
Public ContactXinying Wang
Zhujiang Hospital of Southern Medical University
Outcome results
None listed